CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (NASDAQ: XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic candidates that regulate cellular growth and repair, today reported that its collaboration partner, Celgene, and investigators on the sotatercept program will present preclinical and interim clinical data at the American Society of Nephrology (ASN) Kidney Week 2015, being held in San Diego, CA on November 3-8, 2015.
Help employers find you! Check out all the jobs and post your resume.
